Patents by Inventor Brian P. Fiske

Brian P. Fiske has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIGEN-BINDING PROTEIN CONSTRUCTS AND ANTIBODIES AND USES THEREOF
    Publication number: 20240158493
    Abstract: Provided herein are antigen-binding protein constructs and antibodies and uses of the same.
    Type: Application
    Filed: April 5, 2022
    Publication date: May 16, 2024
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • ANTI-MET ANTIBODIES AND USES THEREOF
    Publication number: 20240141065
    Abstract: Provided herein are antibodies and uses of the same.
    Type: Application
    Filed: February 3, 2022
    Publication date: May 2, 2024
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Brian P. Fiske, Nimish Gera, Alexander J. Nichols
  • ANTI-MET ANTIBODIES AND USES THEREOF
    Publication number: 20240101688
    Abstract: Provided herein are antibodies and uses of the same.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 28, 2024
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Brian P. Fiske, Nimish Gera, Alexander J. Nichols
  • ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
    Publication number: 20220324969
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding CD33 or an epitope of CD33 presented on the surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 13, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
    Publication number: 20220313845
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding DLL3 or an epitope of DLL3 presented on the surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 6, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
    Publication number: 20220306751
    Abstract: Provided herein are antigen-binding protein constructs and uses of the same.
    Type: Application
    Filed: September 11, 2020
    Publication date: September 29, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
    Publication number: 20220298260
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding FOLR1 or an epitope of FOLR1 presented on the surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 22, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
    Publication number: 20220288219
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding CD22 or an epitope of CD22 presented on the surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: July 8, 2020
    Publication date: September 15, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
    Publication number: 20220281984
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding MET or an epitope of MET presented on surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 8, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera